NCT06235398View on ClinicalTrials.gov

Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

February 1, 2028

Study Completion Date

February 1, 2028

Conditions

Myelodysplastic Syndromes

Interventions

BIOLOGICAL

Hematopoietic stem-cell transplantation

Upfront related donor transplantation

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER